Letter Sequence Other |
|---|
EPID:L-2017-PMP-0014, Shine Medical Technologies, Inc., Submittal of Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001 (Open) |
Initiation
- Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request
- Acceptance...
Results
Other: ML18054A077, ML18087A340, ML18127B706, ML18128A034, ML18155A603, ML18162A117, ML18162A118, ML18162A129, ML18193A141, ML18268A344, ML18340A171, ML18340A276, ML19015A352, ML19071A185
|
MONTHYEARML18030A7422017-07-14014 July 2017
Irrevocable Standby Letter of Credit (Redacted)
Project stage: Request
ML18054A0772018-03-0808 March 2018
Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Other
ML18092A0872018-03-27027 March 2018
Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Request
ML18087A3892018-03-28028 March 2018
Meeting Slides for the April 3, 2018, Public Meeting Between Shine Medical Technologies. Inc. and the NRC
Project stage: Request
ML18162A0542018-03-28028 March 2018, 29 March 2018, 3 April 2018, 18 June 2018
Shine Medical Technologies, Inc. April 3, 2018 Public Meeting
Project stage: Request
ML18096A6882018-04-0303 April 2018
Confirmatory Action Letter (CAL) No. NRR-2011-001
Project stage: Request
ML18096A4552018-04-0303 April 2018
Shine Operating License Pre-Application Meeting (Environmental Presentation Slides)
Project stage: Request
ML18087A3402018-04-0303 April 2018
Response to Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Other
ML18096A6892018-04-0303 April 2018
Arrr Restart Plan (4/3/2018) Approach to Critical, Control Rod and Power Calibrations
Project stage: Request
ML18130A5782018-05-0707 May 2018
Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Request
ML18162A1362018-05-11011 May 2018, 18 June 2018
Shine Medical Technologies, Inc. May 23, 2018 Public Meeting
Project stage: Request
ML18138A2912018-05-16016 May 2018
Shine Medical Technologies, Inc. - Submittal of Meeting Slides for the May 23 and 24, 2018 with NRC
Project stage: Request
ML18128A0342018-05-16016 May 2018
Response to Second Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Other
ML18156A1302018-06-0101 June 2018
Inc. - Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Request
ML18155A6032018-06-0707 June 2018
Response to Third Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Other
ML18162A1172018-06-18018 June 2018
Shine Medical Technologies Acknowledgment of Receipt of 2016 Annual Financial Report
Project stage: Other
ML18162A0552018-06-18018 June 2018
Shine Medical Technologies April 3, 2018 Public Meeting Summary
Project stage: Meeting
ML18162A1162018-06-18018 June 2018
Shine Medical Technologies Annual Financial Report
Project stage: Request
ML18162A1182018-06-18018 June 2018
Shine Medical Technologies Response to Request for Withholding Letter for 2016 Annual Financial Report
Project stage: Other
ML18162A1292018-06-18018 June 2018
Shine Medical Technologies, Inc. - Acknowledgment of Receipt of Periodic Reports on Construction Permit Conditions
Project stage: Other
ML18162A1382018-06-18018 June 2018
May 23-24, 2018, Summary of Meeting with Shine Medical Technologies, Inc
Project stage: Meeting
ML18127B7062018-06-21021 June 2018
Closure of NRC Confirmatory Action Letter No. NRR-2011-001
Project stage: Other
ML18221A4532018-06-27027 June 2018, 17 August 2018
Shine Medical Technologies, Inc. June 2018 Public Meeting
Project stage: Request
ML18187A2162018-07-0202 July 2018
Resubmittal of Meeting Slides for the June 28, 2018, Public Meeting Between Shine Medical Technologies, Inc. and the NRC
Project stage: Request
ML18197A0802018-07-10010 July 2018
Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Request
ML18193A1412018-07-16016 July 2018
Response to Fourth Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Other
ML18277A1962018-07-17017 July 2018
Amendment to Standby Letter of Credit (Redacted)
Project stage: Request
ML18206A7262018-07-18018 July 2018
Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor (Redacted)
Project stage: Request
ML18221A4542018-08-17017 August 2018
Summary of Meeting with Shine Medical Technologies, Inc.
Project stage: Meeting
ML18239A2192018-08-27027 August 2018
Request for Confirmation of the 10 CFR Part 140 Financial Protection Requirements for the Shine Facility
Project stage: Request
ML18268A3442018-10-0202 October 2018
Letter of Appreciation for the Tour of the Research Test Reactor Fuel Fabrication Facility Provided to the U.S. Nuclear Regulatory Commission on August 21, 2018 EPID No. L-2017-PMP-0014
Project stage: Other
ML18340A1712018-12-10010 December 2018
Shine Medical Technologies, Inc. - Acknowledgement of Receipt of Periodic Report on Construction Permit Conditions
Project stage: Other
ML18340A2762018-12-19019 December 2018
Shine Medical Technologies, Inc. - Acknowledgment of Receipt of Request for Confirmation of Applicable Financial Protection Requirements
Project stage: Other
ML19025A2642019-01-22022 January 2019
Shine Medical Technologies, Inc. Submittal of Meeting Slides for the January 29 and 30, 2019 Meeting with the NRC
Project stage: Request
ML19024A3522019-01-22022 January 2019
Shine Medical Technologies - Meeting Slides for the January 31, 2019 Public Meeting Between Shine Medical Technologies, Inc. and the NRC
Project stage: Request
ML19025A2752019-01-22022 January 2019
Shine Medical Technologies, Inc. Submittal of Meeting Slides for the January 29 and 30, 2019 Meeting with the NRC
Project stage: Request
ML19015A3522019-02-15015 February 2019
Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Other
ML19071A1852019-03-22022 March 2019
Shine Medical Technologies, Inc. - Request for Withholding from Public Disclosure
Project stage: Other
ML19071A1812019-03-22022 March 2019
Shine Medical Technologies, Inc. - January 31, 2019 Public Meeting Summary
Project stage: Meeting
ML19071A1792019-03-22022 March 2019
Shine Medical Technologies, Inc. January 31, 2019 Public Meeting
Project stage: Request
ML19071A1802019-03-22022 March 2019
Shine Medical Technologies, Inc. - Request for Withholding Information from Public Disclosure
Project stage: Withholding Request Acceptance
2018-06-18
[Table View] |
|
|---|
Category:Letter
MONTHYEARIR 05000228/20230012024-02-0505 February 2024
NRC Inspection Report 050-00228/2023-001, Disputed Cited Violation and Minor Violation Revised, EA-23-118
ML23279A1062023-10-0202 October 2023
Response to Violation 05000228/2023001-001B
ML23255A0342023-09-0909 September 2023
Response to Violation 050-00228/2023-001-00lA
ML23255A0362023-09-0909 September 2023
Response to Inspection Report 050-00228/2023-001
ML23219A1882023-08-24024 August 2023
NRC Inspection Report 05000228/2023001, and Notice of Violation
ML23187A0562023-07-0101 July 2023
Radiation Safety Officer Change Update
ML23187A0582023-07-0101 July 2023
July 1, 2022 Thru June 30, 2023 Summary of Changes, Tests, and Experiments
ML23157A0662023-05-24024 May 2023
Letter from David Slaughter, Aerotest Operations, Inc. Inadequate Oversight of Non-Power Reactor OIG Case No. 21-012 and Requested Payment for Damages Caused by the Nrc'S Inadequate Oversight
ML22361A1022023-02-24024 February 2023
Reactor Decommissioning Branch Project Management Changes for Some Decommissioning Facilities and Establishment of Backup Project Manager for All Decommissioning Facilities
ML22340A0062022-11-16016 November 2022
Reference Documents from Decommissioning Plan
ML22215A1522022-07-21021 July 2022
Aerotest Radiography and Research Reactor - AO RAI Responses for Decommissioning Plan
ML22187A0852022-07-0101 July 2022
Inc - July 1, 2021 Thru June 30, 2022 Summary of Changes, Tests, and Experiments
ML22152A2522022-06-28028 June 2022
Request for Additional Information on Review of Request for Amendment to Approve Decommissioning Plan, Arrr (License No. R-98, Docket No. 50-228)
ML22060A2602022-03-21021 March 2022
Change in NRC Staff Project Management Responsibility for the Aerotest Radiography and Research Reactor
ML22040A1992022-03-0909 March 2022
Examination Confirmation Letter No. 50-288/OL-22-03, Reed College
ML22025A2002022-01-20020 January 2022
Amendment to AO Decommissioning Plan Submittal Letter Dated July 20, 2021, Agencywide Documents Access, and Management System (ADAMS) Accession No. ML21230A304
ML21307A3242022-01-12012 January 2022
Request for Supplemental Information for Decommissioning Plan, Arrr (License R-98, Docket 50-228)
ML21344A0332022-01-0303 January 2022
Aerotest Letter from the Chief Financial Officer Regarding Additional Information for the Fees Assessed Under to Aerotest Operations, Inc. (Aerotest) within Invoice Number Lfb 22-0346
ML21361A0472021-12-21021 December 2021
Response to December 6, 2021 NRC Pol Issuance; the Licensee and Its Reactor Safeguard Committee Request a Reasonable Opportunity to Review and Address Short Comings of the Draft Licensee and Technical Specifications Along with the Draft Sa
ML21242A4632021-12-0606 December 2021
Issuance of License Amendment No. 6 to Facility Operating License No. R-98 for the Aerotest Radiography and Research Reactor with Partial Denial of Amendment Request
ML21307A1252021-10-28028 October 2021
Letter Regarding Charges Billed
ML21209A5192021-07-20020 July 2021
Aerotest Radiography and Research Reactor, Response to NRC Letter Dated July 12, 2021 (ML21188A391)
ML21230A3042021-07-20020 July 2021
Decommissioning Plan Submittal (Redacted)
ML21147A3732021-07-19019 July 2021
Correction of Letters Regarding Closure of Confirmatory Action Letter No. NRR-04-003 and Review of Physical Security Plan
ML21188A3912021-07-12012 July 2021
Inc. - Revised Completion Date Possession-Only License Amendment Request for the Aerotest Radiography and Research Reactor Facility Operating License
ML21188A2162021-07-0101 July 2021
July 1, 2020 Through June 30, 2021 Summary of Changes, Tests, and Experiments
ML21193A0892021-07-0101 July 2021
Emergency Plan (Redacted)
ML21181A1232021-06-22022 June 2021
License and TS Amendments
ML21147A0602021-05-19019 May 2021
Response to RAI 28 and 29
ML21056A3172021-04-30030 April 2021
CFO Response to Aerotest November 11 2020 Letter
ML21126A1502021-04-28028 April 2021
License and TS Amendments
ML21098A1572021-03-31031 March 2021
Response to RAI CFH Training and Requalification Program- 3/30/21
ML21118A0252021-03-30030 March 2021
Confirmatory Order
ML21047A4682021-03-30030 March 2021
Request for Additional Information Possession-Only License Amendment Request for the Aerotest Radiography and Research Reactor Facility Operating License No. R-98
ML21034A6262021-03-12012 March 2021
Request for Additional Information Possession-Only License Amendment Request for the Aerotest Radiography and Research Reactor Facility Operating License No. R-098
ML21048A1392021-03-0505 March 2021
Acknowledgement of Letter Regarding Decommissioning Plan and Exercise of Enforcement Discretion
ML21004A0792021-01-0707 January 2021
Review of Physical Security Plan in Support of Possession-Only License Amendment Request License No. R-98
ML20345A0312020-12-28028 December 2020
CFO Response to Aerotest November 2020 Letter Re Lfb 20-1849
IR 05000228/20202022020-12-10010 December 2020
U.S. Nuclear Regulatory Commission Security Inspection Report No. 05000228/2020202 and Notice of Violation - Non-OUO-SRI (Cover Letter)
ML20332A0322020-11-18018 November 2020
Unable to Submit Decommissioning Plan by December 5, 2020 Due to COVID-19
ML20295A4242020-11-16016 November 2020
Notification of Mailing Address Change Regarding Submittal of Fingerprint Cards
ML20325A1762020-11-11011 November 2020
Response to NRC CFO, Letter Dated April 18, 2019 Re Reimbursement Request for Activities Associated with the Fees That Were Not Performed in a Satisfactory Manner
ML20325A1342020-11-10010 November 2020
Letter Disputing to Make Payment for Services That Are Not or Poorly Rendered
ML20289A4772020-10-23023 October 2020
Aerotest Response Letter from D. Slaughter Dated September 14, 2020 Docket 50-228
ML20304A1532020-10-21021 October 2020
Response to Notice of Violation
IR 05000228/20202012020-10-15015 October 2020
U.S. Nuclear Regulatory Commission Routine Inspection Report No. 05000228/2020201 and Notice of Violation
ML20276A2472020-09-28028 September 2020
Aerotest Radiography and Research Reactor - Updated Arrr Security Plan
ML20234A6312020-09-17017 September 2020
Request for Clarification Physical Security Plan Review - Cover Letter - (Public Version)
ML20248H4602020-08-28028 August 2020
Inc - List of Explanations, Changes, and Justifications for Raj CFH Training and Requalification Program
ML20177A2032020-07-27027 July 2020
Request for Additional Information Possession-Only License Amendment Request to Use Certified Fuel Handlers for the Aerotest Radiography and Research Reactor Facility Operating License No. R-98
2024-02-05
[Table view] |
Text
July 16, 2018 Dr. David M. Slaughter, President and Reactor Administrator Aerotest Operations, Inc.
3455 Fostoria Way San Ramon, CA 94583
SUBJECT:
AEROTEST OPERATIONS, INC. - RESPONSE TO FOURTH REQUEST FOR EXTENSION OF TIME TO RESPOND TO LETTER REGARDING IRREVOCABLE STANDBY LETTER OF CREDIT FOR THE AEROTEST RADIOGRAPHY AND RESEARCH REACTOR (EPID NO. L-2017-PMP-0014)
Dear Dr. Slaughter:
By letter dated March 8, 2018 (Agencywide Documents Access and Management System (ADAMS) Accession No. ML18054A077), the U.S. Nuclear Regulatory Commission (NRC) staff sent Aerotest Operations, Inc. (Aerotest) a request that Aerotest respond within 30 days of its receipt of that letter to explain how it complies, or plans on complying, with the license transfer condition that its irrevocable standby letter of credit conforms to the guidance provided in NRC Regulatory Guide (RG) 1.159, Assuring the Availability of Funds for Decommissioning Nuclear Reactors. The current version of RG 1.159, Revision 2, dated October 2011, may be found at ADAMS Accession No. ML112160012.
By letters dated March 27, 2018; May 7, 2018; and June 1, 2018 (ADAMS Accession Nos. ML18092A087, ML18130A578, and ML18156A130, respectively), Aerotest requested additional time beyond the deadline in the NRC staffs March 8, 2018, letter to respond to the March 8, 2018, letter. The NRC staff accepted Aerotests respective requests by letters dated April 3, 2018; May 16, 2018; and June 7, 2018 (ADAMS Accession Nos. ML18087A340, ML18128A034, and ML18155A603, respectively).
By letter dated July 10, 2018 (ADAMS Accession No. ML18197A080), Aerotest requested that the deadline to respond to the NRC staffs March 8, 2018, letter be extended again such that the new deadline would be 120 days beyond the original deadline to respond to the NRC staffs March 8, 2018, letter. Aerotest stated that its July 10, 2018, extension request was necessary because it is awaiting acceptance of language for the letter of credit by Bank of the West (BoW),
or the proposal of alternate language by BoW. Aerotest additionally stated that, in the event BoW is unable to accept the necessary language for the letter of credit, Aerotest is also working with an alternate financial institution to furnish an acceptable letter of credit.
The NRC staff accepts Aerotests fourth extension request dated July 10, 2018.
In its letter dated July 10, 2018, Aerotest also discussed possible language for a letter of credit to require notice to Aerotest and the NRC of events that could affect the issuing financial institutions ability to fulfill its obligation under the letter of credit. The NRC staff notes that this language differs from the RG 1.159, Appendix A-5, example wording for an irrevocable standby
D. Slaughter letter of credit for a nuclear reactor licensee. The NRC staff notes that, if Aerotest submitted a revised letter of credit with language that differs from the example wording in RG 1.159, Appendix A-5, the NRC staff would review the alternative language to determine whether the letter of credit adequately conforms to the guidance in RG 1.159, as required by the license transfer condition, or whether additional revisions to the letter of credit are required.
If you have any questions, or need additional time to respond to the NRC staffs original March 8, 2018, request please contact me at 301-415-4067, or by electronic mail at Edward.Helvenston@nrc.gov.
Sincerely,
/RA/
Edward Helvenston, Project Manager Research and Test Reactors Licensing Branch Division of Licensing Projects Office of Nuclear Reactor Regulation Docket No. 50-228 License No. R-98 cc: Sandy Warren, General Manager Aerotest Operations, Inc.
3455 Fostoria Way San Ramon, CA 94583 California Energy Commission 1516 Ninth Street, MS-34 Sacramento, CA 95814 Radiologic Health Branch P.O. Box 997414, MS 7610 Sacramento, CA 95899-7414 Test, Research and Training Reactor Newsletter P.O. Box 118300 University of Florida Gainesville, FL 32611
ML18193A141 *concurred via email OFFICE NRR/DLP/PRLB/PM* NRR/DLP/LA* NRR/DLP/PRLB/BC NRR/DLP/PRLB/PM NAME EHelvenston NParker AAdams EHelvenston DATE 7/16/2018 7/13/2018 7/16/2018 7/16/2018